EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Preventing Atherosclerotic Cardiovascular Disease in Young Male Androgen Abusers

Peter Bond iD, Diederik L Smit, Tijs Verdegaal, Willem de Ronde

Clinical Cardiology · 2026-02 · 49 (2)

DOI: 10.1002/clc.70257 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Cardiology, online erschienen am 19.02.2026. Verfasst von Peter Bond und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Performance and Image-Enhancing Drugs Research, Android Health Clinic, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Atherosclerosis, Androgens. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Anti-Doping Authority (Dopingautoriteit Nederland).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Androgen abuse among young men is a prevalent yet under recognized risk factor for atherosclerotic cardiovascular disease (ASCVD). Supraphysiological androgen exposure adversely affects lipoprotein profiles, blood pressure, and vascular function, potentially accelerating atherosclerosis even in otherwise healthy individuals. Conventional cardiovascular risk prediction models may underestimate risk in this population due to fluctuating biomarker profiles and other unaccounted risk‐increasing factors that are not captured in these models.

Objectives

To review the mechanisms by which androgen abuse contributes to ASCVD, to highlight limitations of traditional risk stratification tools in this population, and to propose tailored approaches to risk assessment and prevention.

Methods

Narrative review of epidemiological, imaging, and mechanistic studies examining cardiovascular risk factors and subclinical atherosclerosis in androgen abusers.

Results

Available evidence indicates that androgen abuse adversely affects lipid profiles, blood pressure, and vascular endothelial function, and is associated with increased subclinical atherosclerosis. Conventional risk prediction models may underestimate risk in this population due to young age, fluctuating biomarker profiles, and cumulative exposure effects not captured by standard algorithms.

Conclusions

Androgen abuse should be recognized as a cardiovascular risk‐enhancing factor in young men. Individualized risk assessment beyond traditional calculators may be warranted to guide preventive strategies in selected patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisAndrogensHumansMaleRisk AssessmentHeart Disease Risk FactorsRisk FactorsBiomarkersAnabolic Androgenic SteroidsAge Factors

Stichwörter der Autor:innen

anabolic steroidsandrogensatherosclerosistestosterone

Substanzen

AndrogensBiomarkersAnabolic Androgenic Steroids

Autor:innen und Institutionen

  • Department of Performance and Image-Enhancing Drugs Research, Android Health Clinic, Utrecht, the Netherlands.
  • Department of Internal Medicine, Zaandam Medical Centre, Zaandam, the Netherlands.
  • Department of Internal Medicine, Spaarne Gasthuis, Haarlem, the Netherlands.

ORCID-Profile: Peter Bond

Förderung

  • Dutch Anti-Doping Authority (Dopingautoriteit Nederland)

Zitieren

APA

Bond, P., Smit, D. L., Verdegaal, T., & de Ronde, W. (2026). Preventing Atherosclerotic Cardiovascular Disease in Young Male Androgen Abusers. Clinical Cardiology, 49(2). https://doi.org/10.1002/clc.70257

Vancouver

Bond P, Smit DL, Verdegaal T, de Ronde W. Preventing Atherosclerotic Cardiovascular Disease in Young Male Androgen Abusers. Clinical Cardiology. 2026;49(2). doi:10.1002/clc.70257

BibTeX
@article{Bond2026,
  author = {Bond, Peter and Smit, Diederik L and Verdegaal, Tijs and de Ronde, Willem},
  title = {Preventing Atherosclerotic Cardiovascular Disease in Young Male Androgen Abusers},
  journal = {Clinical Cardiology},
  year = {2026},
  volume = {49},
  number = {2},
  doi = {10.1002/clc.70257}
}
Kostenlos starten →